From Bench to Backing: Inside BioLabs Investor Day at the Curtis
A full day in Philadelphia where startups, investors, and partners came together to define
Biohealth Capital Region
Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Greater Philadelphia
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
Research Triangle Park
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →Featured News
Biohealth Capital Region
Workforce
‘Tis the Season… for Performance Reviews
'Tis the Season… for Performance Reviews Performance reviews, often seen as dreadful, can become valuable opportunities for feedback and growth when integrated into a well-structured…
Read More →Latest News
Chandra Ramanathan Elected Executive Chair of Nucleate’s Board to Advance Its Global Mission, Talent, and Innovation Ecosystem
Photo credit: Nucleate Boston, MA — April 22nd, 2026 — Nucleate, the global nonprofit dedicated to empowering the next generation of biotech leaders, today announced the election of Chandra Ramanathan, Ph.D., M.B.A. as Executive Chair of its Board of Directors. Chandra brings more than two decades of leadership experience across biopharma and academia, with a proven track record of […]
Retiring the V-Model: Why Pharma CQV Is Moving Toward Smarter, Risk-Based Execution
For decades, commissioning and qualification (C&Q) in pharmaceutical manufacturing has been shaped by a familiar structure: the V-Model. It’s orderly, heavily documented, and built on the idea that more testing equals more certainty. But in today’s manufacturing landscape—where speed, flexibility, and regulatory clarity all matter at once—that model is starting to show its age. A […]
Three Philly-Area Startups Accelerating Breakthroughs and Milestones with Lean Commercialization Approach
Greater Philadelphia continues to emerge as a hotbed for medical device and biotech innovation, producing nimble startups that are advancing solutions for vision restoration, pain management, and critical manufacturing processes. Three such companies recently presented at the 2nd Annual Kymanox Showcase in Cary, NC. Each is advancing sophisticated technologies while staying lean, hitting key milestones, […]
Greater Philadelphia-based Aprea Therapeutics Raises $30M to Extend Runway and Reposition Its Precision Oncology Bet
Aprea Therapeutics announced the $30 million private placement it closed in early April to advance a new lead program. After a period marked by clinical setbacks and strategic recalibration, Aprea is stepping back into the capital markets with a new lead program, a refined focus, and a familiar challenge: proving that its science can translate […]
Hyper-Virtual Wins: How Lean, Virtual Teams Are Reducing Drug Development Time
At the 2nd Annual Kymanox Showcase, powered by Seed2Table Life Science, founders presented technologies addressing challenges across multiple life science modalities. Collectively, these companies raised more than $25 million in the past year while operating with lean, hypervirtual teams. All of the participating founders and teams are operating leaner, moving faster, and tackling highly complex […]
Behind Every Therapy: How Analytical Sciences Can Impact Speed and Success
At Minaris Advanced Testing's Navy Yard headquarters, BioBuzz kicked off its Philadelphia Insights to Impact (I2I) series with a frank conversation about the discipline that increasingly determines whether a therapy reaches the patient — and when.
Pinnacle Medicines’ $89M Raise Signals a New Bet on Oral Peptides—and a Different Kind of Biotech Build
In today’s biotech market, raising capital isn’t just about advancing a pipeline—it’s about convincing investors that your model for building a company is worth backing. For Pinnacle Medicines, the $89 million Series B it closed in late March does both. The round, co-led by Foresite Capital and LAV Fund, positions the young company as one […]
National Conference for Bioscience Financial Officers is Coming to Philadelphia – “One More Round”
In life sciences, progress rarely follows a straight line. Companies move from discovery to development, from promise to proof, navigating a landscape shaped as much by capital and strategy as it is by science. And for the leaders responsible for steering that journey—the CFOs and financial operators behind biotech and medtech companies—the challenge today is […]